Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1954 1
1961 1
1962 1
1963 2
1964 1
1965 1
1967 3
1970 1
1971 1
1973 2
1974 2
1975 1
1976 5
1977 5
1978 2
1979 4
1980 2
1981 5
1982 1
1984 5
1985 3
1986 2
1987 5
1988 4
1990 4
1991 3
1992 5
1993 3
1994 1
1995 5
1996 1
1997 1
1998 2
2000 2
2001 3
2002 1
2003 2
2004 5
2006 2
2007 4
2008 7
2009 5
2010 3
2011 5
2012 3
2013 3
2014 3
2015 6
2016 4
2017 8
2018 3
2019 4
2020 2
2021 1
2022 2
2023 2
2024 3
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. Conroy T, et al. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923. N Engl J Med. 2011. PMID: 21561347 Free article. Clinical Trial.
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.
Edeline J, Benabdelghani M, Bertaut A, Watelet J, Hammel P, Joly JP, Boudjema K, Fartoux L, Bouhier-Leporrier K, Jouve JL, Faroux R, Guerin-Meyer V, Kurtz JE, Assénat E, Seitz JF, Baumgaertner I, Tougeron D, de la Fouchardière C, Lombard-Bohas C, Boucher E, Stanbury T, Louvet C, Malka D, Phelip JM. Edeline J, et al. Among authors: joly jp. J Clin Oncol. 2019 Mar 10;37(8):658-667. doi: 10.1200/JCO.18.00050. Epub 2019 Feb 1. J Clin Oncol. 2019. PMID: 30707660 Clinical Trial.
[Can liver needle biopsy be standardized?].
Joly JP, Capron D. Joly JP, et al. Gastroenterol Clin Biol. 2001 Jan;25(1):71-2. Gastroenterol Clin Biol. 2001. PMID: 11275618 Free article. Review. French. No abstract available.
What is the prognostic significance of acrometastases?
Baltazard T, Arnault JP, Dillied AS, Joly JP, Lok C. Baltazard T, et al. Among authors: joly jp. Dermatol Online J. 2015 Sep 17;21(9):13030/qt53k593w6. Dermatol Online J. 2015. PMID: 26437291 Free article.
Management of colon cancer in patients with cirrhosis: A review.
Sabbagh C, Cosse C, Chauffert B, Nguyen-Khac E, Joly JP, Yzet T, Regimbeau JM. Sabbagh C, et al. Among authors: joly jp. Surg Oncol. 2015 Sep;24(3):187-93. doi: 10.1016/j.suronc.2015.06.010. Epub 2015 Jun 12. Surg Oncol. 2015. PMID: 26093942 Review.
Alkoxyamines Designed as Potential Drugs against Plasmodium and Schistosoma Parasites.
Reyser T, To TH, Egwu C, Paloque L, Nguyen M, Hamouy A, Stigliani JL, Bijani C, Augereau JM, Joly JP, Portela J, Havot J, Marque SRA, Boissier J, Robert A, Benoit-Vical F, Audran G. Reyser T, et al. Among authors: joly jp. Molecules. 2020 Aug 24;25(17):3838. doi: 10.3390/molecules25173838. Molecules. 2020. PMID: 32846996 Free PMC article.
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies.
Edeline J, Hirano S, Bertaut A, Konishi M, Benabdelghani M, Uesaka K, Watelet J, Ohtsuka M, Hammel P, Kaneoka Y, Joly JP, Yamamoto M, Monard L, Ambo Y, Louvet C, Ando M, Malka D, Nagino M, Phelip JM, Ebata T. Edeline J, et al. Among authors: joly jp. Eur J Cancer. 2022 Mar;164:80-87. doi: 10.1016/j.ejca.2022.01.009. Epub 2022 Feb 16. Eur J Cancer. 2022. PMID: 35182925
165 results